Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2024 Nov 27:15:1415905.
doi: 10.3389/fpsyt.2024.1415905. eCollection 2024.

Enduring effects of psychotherapy, antidepressants and their combination for depression: a systematic review and meta-analysis

Affiliations

Enduring effects of psychotherapy, antidepressants and their combination for depression: a systematic review and meta-analysis

Ulrich Voderholzer et al. Front Psychiatry. .

Abstract

Introduction: Although depressive disorders are frequently associated with relapses, the sustained efficacy of therapies after their termination has been insufficiently investigated.

Objective: The aim of this study was to evaluate the current evidence of enduring effects of psychotherapy, antidepressants and their combination after the end of treatment.

Methods: PubMed and PsychINFO were systematically screened according to PRISMA guidelines (except for preregistration). Only randomized controlled trials (RCTs) between 1980 and 2022 comparing the efficacy of psychotherapy, antidepressants and their combination in adult depression at follow-up at least 12 months after termination of therapy, which could be acute phase, maintenance or relapse prevention therapy, were included. Risk of bias was assessed by using the Cochrane risk of bias tool.

Results: In total 19 RCTs with a total of 1154 participants were included. Psychotherapy was significantly superior to pharmacotherapy regarding relapse rates and Beck Depression Inventory scores at follow-up after acute treatment in two of nine RCTs. Combined treatment performed significantly better than pharmacotherapy, but not psychotherapy, regarding relapse and remission in five out of nine RCTs at least 12 months after treatment termination. Pairwise meta-analyses indicated a superiority of combined treatment compared to pharmacotherapy alone regarding relapse, recurrence, and rehospitalization rates (RR=0.60, 95%-CI: 0.37-0.97, p=.041) and for psychotherapy compared to pharmacotherapy alone regarding relapse and recurrence rates (RR=0.58, 95%-CI: 0.38-0.89, p=.023), however comparative treatment effects between psychotherapy and combined treatment were insignificant.

Conclusions: Current findings suggest a superiority of psychotherapy and combined treatment over pharmacotherapy alone in major depressive disorder depression. Major limitations were a low number of studies reporting follow-up data after termination of study periods and a heterogeneity in definitions of treatment outcomes. Practice guidelines and participatory decision-making processes for the choice of treatment should consider the current knowledge on long-term effects of antidepressant therapy methods more than has been the case to date.

Keywords: antidepressants; carry-over effect; depression; follow-up; long-term; psychotherapy.

PubMed Disclaimer

Conflict of interest statement

Authors ES, WR and UV receive fees for books, lectures and workshops on psychotherapy and pharmacotherapy. The remaining authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Figures

Figure 1
Figure 1
PRISMA flow diagram. N, number of trials; RCT, Randomized Controlled Trial; PT, Psychotheraphy; AD, Antidepresants.
Figure 2
Figure 2
Relapse and recurrence rates between psychotheraphy, pharmacotheraphy, and their combination in depression. Data in parenthesis refer to the length of the follow-up period.
Figure 3
Figure 3
Forest plot and results of pairwise meta-analyses comparing enduring effects of psychotherapy, pharmacotheraphy, and combined treatment in depression.

References

    1. Eaton WW, Shao H, Nestadt G, Lee HB, Bienvenu J, Zandi P, et al. . Population-based study of first onset and chronicity in major depressive disorder. Arch Gen Psychiatry. (2008) 65:513–20. doi: 10.1001/archpsyc.65.5.513 - DOI - PMC - PubMed
    1. Furukawa TA, Shinohara K, Sakher E, Karyotaki E, Miguel C, Charova M, et al. . Initial treatment choices to achieve sustained response in major depression: a systematic review and network meta-analysis. World Psychiatry. (2021) 20:387–96. doi: 10.1002/wps.20906 - DOI - PMC - PubMed
    1. Ormel J, Emmelkamp PM. More treatment, but not less anxiety and mood disorders: why? Seven hypotheses and their evaluation. Psychother Psychosomatics. (2023), 1–8. doi: 10.1159/000528544 - DOI - PMC - PubMed
    1. Monroe SM, Harkness KL. Major depression and its recurrences: life course matters. Annu Rev Clin Psychol. (2022) 18:329–57. doi: 10.1146/annurev-clinpsy-072220-021440 - DOI - PubMed
    1. Brakemeier E, Radtke M, Zimmermann J, Tuschen-Caffier B, Hautzinger M, Schramm E, et al. . Overcoming treatment resistance in chronic depression: a pilot study on outcome and feasibility of the cognitive behavioral analysis system of psychotherapy as an inpatient treatment program. Psychother psychosomatics. (2015) 84:51–6. doi: 10.1159/000369586 - DOI - PubMed

Publication types

LinkOut - more resources